These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides. Ryu S; Song PI; Seo CH; Cheong H; Park Y Int J Mol Sci; 2014 May; 15(5):8753-72. PubMed ID: 24840573 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization. Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934 [TBL] [Abstract][Full Text] [Related]
10. Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peschel A; Collins LV Peptides; 2001 Oct; 22(10):1651-9. PubMed ID: 11587793 [TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. Zanger P; Holzer J; Schleucher R; Steffen H; Schittek B; Gabrysch S J Infect Dis; 2009 Dec; 200(12):1907-15. PubMed ID: 19919305 [TBL] [Abstract][Full Text] [Related]
12. Impact of Community-Onset Methicillin-Resistant Bae E; Kim CK; Jang JH; Sung H; Choi Y; Kim MN Ann Lab Med; 2019 Mar; 39(2):158-166. PubMed ID: 30430778 [TBL] [Abstract][Full Text] [Related]
13. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Li M; Cha DJ; Lai Y; Villaruz AE; Sturdevant DE; Otto M Mol Microbiol; 2007 Dec; 66(5):1136-47. PubMed ID: 17961141 [TBL] [Abstract][Full Text] [Related]
14. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Rieg S; Huth A; Kalbacher H; Kern WV Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities. Niebuhr M; Mai U; Kapp A; Werfel T Exp Dermatol; 2008 Nov; 17(11):953-7. PubMed ID: 18557929 [TBL] [Abstract][Full Text] [Related]
16. [The influence of AMPs from HaCaT keratinocytes on some bacteria strains derived from skin changes]. Wiechuła B; Wilk I; Ekiel A; Tustanowski J; Martirosian G Med Dosw Mikrobiol; 2006; 58(2):163-8. PubMed ID: 17133910 [TBL] [Abstract][Full Text] [Related]
18. Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014. Coombs GW; Daley DA; Thin Lee Y; Pearson JC; Robinson JO; Nimmo GR; Collignon P; Howden BP; Bell JM; Turnidge JD; Commun Dis Intell Q Rep; 2016 Jun; 40(2):E244-54. PubMed ID: 27522136 [TBL] [Abstract][Full Text] [Related]
19. Persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human beta-defensin 3 after sterile wounding of healthy skin in vivo. Zanger P; Nurjadi D; Vath B; Kremsner PG Infect Immun; 2011 Jul; 79(7):2658-62. PubMed ID: 21464083 [TBL] [Abstract][Full Text] [Related]
20. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan. Naimi HM; Rasekh H; Noori AZ; Bahaduri MA BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]